Journal
CLINICAL PHARMACOLOGY & THERAPEUTICS
Volume 105, Issue 5, Pages 1256-1262Publisher
WILEY
DOI: 10.1002/cpt.1322
Keywords
-
Categories
Funding
- National Institutes of Health/National Institute of General Medical Sciences (NIH/NIGMS) [R24 GM61374]
- National Institutes of Health/National Human Genome Research Institute (NIH/NHGRI) [U01 HG007419-04]
Ask authors/readers for more resources
The varying frequencies of pharmacogenetic alleles among populations have important implications for the impact of these alleles in different populations. Current population grouping methods to communicate these patterns are insufficient as they are inconsistent and fail to reflect the global distribution of genetic variability. To facilitate and standardize the reporting of variability in pharmacogenetic allele frequencies, we present seven geographically defined groups: American, Central/South Asian, East Asian, European, Near Eastern, Oceanian, and Sub-Saharan African, and two admixed groups: African American/Afro-Caribbean and Latino. These nine groups are defined by global autosomal genetic structure and based on data from large-scale sequencing initiatives. We recognize that broadly grouping global populations is an oversimplification of human diversity and does not capture complex social and cultural identity. However, these groups meet a key need in pharmacogenetics research by enabling consistent communication of the scale of variability in global allele frequencies and are now used by Pharmacogenomics Knowledgebase (PharmGKB).
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available